Shenzhen Stock Exchange: From July 13 to July 17, 2026, the firm adopted self-regulatory measures on a total of 173 cases of abnormal securities transactions, involving abnormal trading situations such as intraday suppression and false declarations; carried out key monitoring of “Wanbang Pharmaceutical”, which recently had serious abnormal stock price fluctuations; verified 19 important matters of listed companies and reported 4 suspected cases of illegal violations to the Securities Regulatory Commission.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.